Product Information
DOXAZOSIN MESYLATE 4 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0911 per EA under NDC 59762139007. Its NADAC has been published 30 times since Dec 3, 2025.
The Low Outlier badge above means this manufacturer's average price in the doxazosin mesylate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762139007
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOXAZOSIN MESYLATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019668On Market Since
9/24/2025
Pharmacological Classes
Price Statistics
The NADAC for DOXAZOSIN MESYLATE 4 MG TAB has been published 30 times since Dec 3, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0911 per EA |
|---|---|
| All-time high | $0.0975 (Apr 15, 2026) |
| All-time low | $0.0911 (Jun 17, 2026) |
| 52-week high | $0.0975 |
| 52-week low | $0.0911 |
| Median price | $0.0955 |
| Average price | $0.0949 |
| Largest weekly change | -5.4% (Jun 17, 2026) |
| Weeks tracked | 30 |
| Tracking since | Dec 3, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DOXAZOSIN MESYLATE 4 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXAZOSIN MESYLATE 4 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.0911 per EA (NDC 59762139007), effective Jun 24, 2026.
How has the price of DOXAZOSIN MESYLATE 4 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXAZOSIN MESYLATE 4 MG TAB has held within roughly two percent of its current level. It has been tracked across 30 weekly CMS publications since Dec 3, 2025.
What are the highest and lowest recorded NADAC prices for DOXAZOSIN MESYLATE 4 MG TAB?
Since Dec 3, 2025, the NADAC for DOXAZOSIN MESYLATE 4 MG TAB has ranged from a low of $0.0911 (Jun 17, 2026) to a high of $0.0975 (Apr 15, 2026), with a median of $0.0955 per EA.
Are there cheaper alternatives to DOXAZOSIN MESYLATE 4 MG TAB?
2 NADAC-published products share the same active ingredient, strength, and dosage form as DOXAZOSIN MESYLATE 4 MG TAB, but none are currently priced below it.
Who manufactures DOXAZOSIN MESYLATE 4 MG TAB?
DOXAZOSIN MESYLATE 4 MG TAB (NDC 59762139007) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification